Kovack Advisors Inc. Buys 298 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Kovack Advisors Inc. raised its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 21.5% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 1,686 shares of the medical equipment provider’s stock after acquiring an additional 298 shares during the period. Kovack Advisors Inc.’s holdings in Intuitive Surgical were worth $880,000 as of its most recent SEC filing.

Several other hedge funds have also bought and sold shares of ISRG. M.E. Allison & CO. Inc. purchased a new stake in shares of Intuitive Surgical in the fourth quarter worth about $449,000. Seilern Investment Management Ltd bought a new stake in Intuitive Surgical in the 4th quarter worth approximately $82,517,000. Sycomore Asset Management raised its holdings in shares of Intuitive Surgical by 27.4% during the 4th quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider’s stock worth $9,214,000 after acquiring an additional 4,079 shares in the last quarter. Exome Asset Management LLC boosted its position in shares of Intuitive Surgical by 16.8% during the 3rd quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock valued at $3,649,000 after acquiring an additional 1,069 shares during the last quarter. Finally, China Universal Asset Management Co. Ltd. grew its holdings in shares of Intuitive Surgical by 5.6% in the fourth quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider’s stock valued at $5,138,000 after purchasing an additional 525 shares in the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insider Buying and Selling at Intuitive Surgical

In related news, EVP Myriam Curet sold 408 shares of Intuitive Surgical stock in a transaction that occurred on Tuesday, February 11th. The shares were sold at an average price of $589.75, for a total transaction of $240,618.00. Following the transaction, the executive vice president now directly owns 353 shares of the company’s stock, valued at $208,181.75. This trade represents a 53.61 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Also, CFO Jamie Samath sold 270 shares of the business’s stock in a transaction that occurred on Tuesday, December 10th. The stock was sold at an average price of $540.15, for a total transaction of $145,840.50. Following the completion of the transaction, the chief financial officer now directly owns 8,757 shares of the company’s stock, valued at $4,730,093.55. This trade represents a 2.99 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 8,077 shares of company stock valued at $4,620,025 in the last ninety days. Corporate insiders own 0.80% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts have commented on the stock. Barclays increased their price objective on shares of Intuitive Surgical from $610.00 to $674.00 in a research report on Monday, January 27th. CICC Research began coverage on shares of Intuitive Surgical in a report on Monday, January 27th. They issued a “neutral” rating and a $550.00 price target for the company. Evercore ISI boosted their price objective on Intuitive Surgical from $490.00 to $530.00 in a research note on Monday, January 27th. Erste Group Bank raised Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Tuesday, November 19th. Finally, Wells Fargo & Company lifted their target price on Intuitive Surgical from $630.00 to $687.00 and gave the stock an “overweight” rating in a report on Friday, January 24th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have assigned a buy rating to the stock. Based on data from MarketBeat, Intuitive Surgical has an average rating of “Moderate Buy” and a consensus target price of $613.10.

Intuitive Surgical Stock Performance

Shares of NASDAQ ISRG opened at $563.77 on Friday. Intuitive Surgical, Inc. has a 52-week low of $364.17 and a 52-week high of $616.00. The firm has a market capitalization of $200.80 billion, a price-to-earnings ratio of 87.95, a PEG ratio of 5.85 and a beta of 1.39. The stock has a 50 day moving average price of $568.89 and a 200 day moving average price of $527.90.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.